OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine
Yupeng Feng, Meng Yuan, John M. Powers, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 695
Open Access | Times Cited: 32
Yupeng Feng, Meng Yuan, John M. Powers, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 695
Open Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
BCG vaccination stimulates integrated organ immunity by feedback of the adaptive immune response to imprint prolonged innate antiviral resistance
Audrey Lee, Katharine Floyd, Shengyang Wu, et al.
Nature Immunology (2023) Vol. 25, Iss. 1, pp. 41-53
Closed Access | Times Cited: 38
Audrey Lee, Katharine Floyd, Shengyang Wu, et al.
Nature Immunology (2023) Vol. 25, Iss. 1, pp. 41-53
Closed Access | Times Cited: 38
In search of a pan-coronavirus vaccine: next-generation vaccine design and immune mechanisms
S. Cankat, M. U. Demael, Leo Swadling
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 103-118
Open Access | Times Cited: 22
S. Cankat, M. U. Demael, Leo Swadling
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 103-118
Open Access | Times Cited: 22
Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination
William N. Voss, Michael L. Mallory, Patrick O. Byrne, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 8, pp. 101668-101668
Open Access | Times Cited: 7
William N. Voss, Michael L. Mallory, Patrick O. Byrne, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 8, pp. 101668-101668
Open Access | Times Cited: 7
Nonhuman primate antigenic cartography of SARS-CoV-2
Annika Rössler, Antonia Netzl, Ninaad Lasrado, et al.
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115140-115140
Open Access
Annika Rössler, Antonia Netzl, Ninaad Lasrado, et al.
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115140-115140
Open Access
Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination
William N. Voss, Michael Mallory, Patrick O. Byrne, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
William N. Voss, Michael Mallory, Patrick O. Byrne, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Recurrent SARS-CoV-2 spike mutations confer growth advantages to select JN.1 sublineages
Qian Wang, Ian A. Mellis, Anthony Bowen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Qian Wang, Ian A. Mellis, Anthony Bowen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Divergent pathogenetic outcomes in BALB/c mice following Omicron subvariant infection
John M. Powers, Sarah R. Leist, Michael L. Mallory, et al.
Virus Research (2024) Vol. 341, pp. 199319-199319
Open Access | Times Cited: 2
John M. Powers, Sarah R. Leist, Michael L. Mallory, et al.
Virus Research (2024) Vol. 341, pp. 199319-199319
Open Access | Times Cited: 2
Neutralizing monoclonal antibodies protect against human adenovirus type 55 infection in transgenic mice and tree shrews
Xinglong Liu, Zhengfeng Li, Xiao Li, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Xinglong Liu, Zhengfeng Li, Xiao Li, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV
Cara W. Chao, Kaitlin R. Sprouse, Marcos C. Miranda, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Cara W. Chao, Kaitlin R. Sprouse, Marcos C. Miranda, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
A comparative immunological assessment of multiple clinical-stage adjuvants for the R21 malaria vaccine in nonhuman primates
Prabhu S. Arunachalam, Na‐Young Ha, S. Moses Dennison, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 758
Closed Access | Times Cited: 2
Prabhu S. Arunachalam, Na‐Young Ha, S. Moses Dennison, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 758
Closed Access | Times Cited: 2
Widespread impact of immunoglobulin V-gene allelic polymorphisms on antibody reactivity
Meng Yuan, Ziqi Feng, Huibin Lv, et al.
Cell Reports (2023) Vol. 42, Iss. 10, pp. 113194-113194
Open Access | Times Cited: 6
Meng Yuan, Ziqi Feng, Huibin Lv, et al.
Cell Reports (2023) Vol. 42, Iss. 10, pp. 113194-113194
Open Access | Times Cited: 6
Broadly potent anti-SARS-CoV-2 antibody shares 93% of epitope with ACE2 and provides full protection in monkeys
Craig Fenwick, Priscilla Turelli, Yoan Duhoo, et al.
Journal of Infection (2023) Vol. 87, Iss. 6, pp. 524-537
Open Access | Times Cited: 5
Craig Fenwick, Priscilla Turelli, Yoan Duhoo, et al.
Journal of Infection (2023) Vol. 87, Iss. 6, pp. 524-537
Open Access | Times Cited: 5
Multi-compartmental diversification of neutralizing antibody lineages dissected in SARS-CoV-2 spike-immunized macaques
Marco Mandolesi, Hrishikesh Das, Liset de Vries, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Marco Mandolesi, Hrishikesh Das, Liset de Vries, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Dose-dependent regulation of immune memory responses against HIV by saponin monophosphoryl lipid A nanoparticle adjuvant
Parham Ramezani-Rad, Ester Marina-Zárate, Laura Maiorino, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Parham Ramezani-Rad, Ester Marina-Zárate, Laura Maiorino, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
ACE2 mimetic antibody potently neutralizes all SARS-CoV-2 variants and fully protects in XBB.1.5 challenged monkeys
Craig Fenwick, Priscilla Turelli, Yoan Duhoo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Craig Fenwick, Priscilla Turelli, Yoan Duhoo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Causes and Consequences of Coronavirus Spike Protein Variability
Fabian Zech, Christoph Jung, Timo Jacob, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 177-177
Open Access
Fabian Zech, Christoph Jung, Timo Jacob, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 177-177
Open Access
Potent neutralization by a receptor binding domain monoclonal antibody with broad specificity for SARS-CoV-2 JN.1 and other variants
Michael S. Piepenbrink, Ahmed Magdy Khalil, Ana C. Chang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Michael S. Piepenbrink, Ahmed Magdy Khalil, Ana C. Chang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Protective Non-neutralizing anti–N-terminal Domain mAb Maintains Fc-mediated Function against SARS-COV-2 Variants up to BA.2.86-JN.1 with Superfluous In Vivo Protection against JN.1 Due to Attenuated Virulence
Arman Izadi, Magdalena Godzwon, Anna Söderlund‐Strand, et al.
The Journal of Immunology (2024) Vol. 213, Iss. 5, pp. 678-689
Closed Access
Arman Izadi, Magdalena Godzwon, Anna Söderlund‐Strand, et al.
The Journal of Immunology (2024) Vol. 213, Iss. 5, pp. 678-689
Closed Access
Computationally designed mRNA-launched protein nanoparticle vaccines
G. Hendricks, Lilit Grigoryan, Mary Jane Navarro, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
G. Hendricks, Lilit Grigoryan, Mary Jane Navarro, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Multi-compartmental diversification of neutralizing antibody lineages dissected in SARS-CoV-2 spike-immunized macaques
Marco Mandolesi, Hrishikesh Das, Liset de Vries, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Marco Mandolesi, Hrishikesh Das, Liset de Vries, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Lessons learnt from broad-spectrum coronavirus antiviral drug discovery
Andrew A. Bolinger, Jun Li, Xuping Xie, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 9, pp. 1023-1041
Closed Access
Andrew A. Bolinger, Jun Li, Xuping Xie, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 9, pp. 1023-1041
Closed Access
Evolving vaccine discovery and development pathways for emerging pathogens
Ashley L. St. John, Eng Eong Ooi
EBioMedicine (2024) Vol. 109, pp. 105445-105445
Closed Access
Ashley L. St. John, Eng Eong Ooi
EBioMedicine (2024) Vol. 109, pp. 105445-105445
Closed Access
Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variants
Michael S. Piepenbrink, Ahmed Magdy Khalil, Ana C. Chang, et al.
npj Viruses (2024) Vol. 2, Iss. 1
Open Access
Michael S. Piepenbrink, Ahmed Magdy Khalil, Ana C. Chang, et al.
npj Viruses (2024) Vol. 2, Iss. 1
Open Access
Maternal Immunization with Adjuvanted Recombinant Receptor-Binding Domain Protein Provides Immune Protection against SARS-CoV-2 in Infant Monkeys
Christopher L. Coe, Francesca A. Nimityongskul, Gabriele R. Lubach, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 929-929
Open Access
Christopher L. Coe, Francesca A. Nimityongskul, Gabriele R. Lubach, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 929-929
Open Access
Sustained exposure to multivalent antigen-decorated nanoparticles generates broad anti-coronavirus responses
Julie Baillet, John H. Klich, Ben S. Ou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Julie Baillet, John H. Klich, Ben S. Ou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
